Last updated on November 2017

Adults with Celiac Disease CO 3920-0001


Brief description of study

ICON Early Phase Services is conducting a research study for adults with celiac disease within the age range of 18-65. This study is being done to test the dosing level of an investigational drug for the treatment of celiac disease. The study drug will be administered by IV infusion.

Clinical Study Identifier: TX133015

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )